ENPP2 and breast carcinoma: The overexpression of ATX, alongside LPAR1 and LPAR2, has been documented across various tumor types, encompassing including ovarian cancer, osteocarcinoma, metastatic melanoma, neuroblastoma, breast cancer, pancreatic cancer, prostate cancer, and hepatocellular carcinoma [23].